J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M300228-JLR200 on August 16, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M300228-JLR200v1
44/12/2339    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kitchens, R. L.
Right arrow Articles by O'Keefe, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitchens, R. L.
Right arrow Articles by O'Keefe, G. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 44, 2339-2348, December 2003
Copyright © 2003 by American Society for Biochemistry and Molecular Biology

Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins

Richard L. Kitchens1,*, Patricia A. Thompson*, Robert S. Munford*,{dagger} and Grant E. O'Keefe§,**

* Departments of Internal Medicine, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9113
{dagger} Microbiology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9113
§ Surgery, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9113
** Department of Surgery, University of Washington, Harborview Medical Center, Seattle, WA 98104-2499

1 To whom correspondence should be addressed. e-mail: richard.kitchens{at}utsouthwestern.edu

Circulating lipoproteins are thought to play an important role in the detoxification of lipopolysaccharide (LPS) by binding the bioactive lipid A portion of LPS to the lipoprotein surface. It has been assumed that hypocholesterolemia contributes to inflammation during critical illness by impairing LPS neutralization. We tested whether critical illness impaired LPS binding to lipoproteins and found, to the contrary, that LPS binding was enhanced and that LPS binding to the lipoprotein classes correlated with their phospholipid content. Whereas low serum cholesterol was almost entirely due to the loss of esterified cholesterol (a lipoprotein core component), phospholipids (the major lipoprotein surface lipid) were maintained at near normal levels and were increased in a hypertriglyceridemic subset of septic patients. The levels of phospholipids found in the LDL and VLDL fractions varied inversely with those in the HDL fraction, and LPS bound predominantly to lipoproteins in the LDL and VLDL fractions when HDL levels were low. Lipoproteins isolated from the serum of septic patients neutralized the bioactivity of the LPS that had bound to them.

Our results show that the host response to acute inflammation and infection tends to maintain lipoprotein phospholipid levels and that, despite hypocholesterolemia and reduced HDL levels, circulating lipoproteins maintain their ability to bind and neutralize an important bacterial agonist, LPS.

Supplementary key words sepsis • acute phase • endotoxemia • hypocholesterolemia • hypertriglyceridemia


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Innate ImmunityHome page
K.A. E. Kallio, K. Buhlin, M. Jauhiainen, R. Keva, A. M. Tuomainen, B. Klinge, A. Gustafsson, and P. J. Pussinen
Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients
Innate Immunity, August 1, 2008; 14(4): 247 - 253.
[Abstract] [PDF]


Home page
Innate ImmunityHome page
N. Bartolome, B. Arteta, M. J. Martinez, Y. Chico, and B. Ochoa
Kupffer cell products and interleukin 1? directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes
Innate Immunity, August 1, 2008; 14(4): 255 - 266.
[Abstract] [PDF]


Home page
J. Lipid Res.Home page
L. Li, P. A. Thompson, and R. L. Kitchens
Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors
J. Lipid Res., August 1, 2008; 49(8): 1782 - 1793.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
H. Sasaki and S. H. White
Aggregation Behavior of an Ultra-Pure Lipopolysaccharide that Stimulates TLR-4 Receptors
Biophys. J., July 15, 2008; 95(2): 986 - 993.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
G. Hergenc, A. Onat, I. Sari, M. Yazici, B. Eryonucu, and G. Can
Serum Total and High-Density Lipoprotein Phospholipid Levels in a Population-Based Study and Relationship to Risk of Metabolic Syndrome and Coronary Disease
Angiology, March 1, 2008; 59(1): 26 - 35.
[Abstract] [PDF]


Home page
J. Immunol.Home page
P. A. Thompson and R. L. Kitchens
Native High-Density Lipoprotein Augments Monocyte Responses to Lipopolysaccharide (LPS) by Suppressing the Inhibitory Activity of LPS-Binding Protein
J. Immunol., October 1, 2006; 177(7): 4880 - 4887.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Stedman, C. Liddle, S. Coulter, J. Sonoda, J. G. Alvarez, R. M. Evans, and M. Downes
Benefit of farnesoid X receptor inhibition in obstructive cholestasis
PNAS, July 25, 2006; 103(30): 11323 - 11328.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
P. Aspichueta, B. Perez-Agote, S. Perez, B. Ochoa, and O. Fresnedo
Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver
Innate Immunity, June 1, 2006; 12(3): 181 - 191.
[Abstract] [PDF]


Home page
Innate ImmunityHome page
R. L. Kitchens and P. A. Thompson
Modulatory effects of sCD14 and LBP on LPS-host cell interactions
Innate Immunity, August 1, 2005; 11(4): 225 - 229.
[Abstract] [PDF]


Home page
Innate ImmunityHome page
R. S. Munford
Invited review: Detoxifying endotoxin: time, place and person
Innate Immunity, April 1, 2005; 11(2): 69 - 84.
[Abstract] [PDF]


Home page
Innate ImmunityHome page
J. F.P. Berbee, L. M. Havekes, and P. C.N. Rensen
Apolipoproteins modulate the inflammatory response to lipopolysaccharide
Innate Immunity, April 1, 2005; 11(2): 97 - 103.
[Abstract] [PDF]


Home page
J. Lipid Res.Home page
W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld
Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.